# Treatment of Sodium Retention in Liver Cirrhosis With Dexamethasone

> **NCT01311167** · PHASE3 · TERMINATED · sponsor: **Insel Gruppe AG, University Hospital Bern** · enrollment: 2 (actual)

## Conditions studied

- Liver Cirrhosis

## Interventions

- **DRUG:** Dexamethasone
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01311167
- **Lead sponsor:** Insel Gruppe AG, University Hospital Bern
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2011-02
- **Primary completion:** 2011-11
- **Final completion:** 2011-11
- **Target enrollment:** 2 (ACTUAL)
- **Why stopped:** Recruitment problems (not enough patients were found who met eligibility criteria)
- **Last updated:** 2013-04-18

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01311167

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01311167, "Treatment of Sodium Retention in Liver Cirrhosis With Dexamethasone". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01311167. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*